INTRODUCTION
Psoriasis a non-contagious, non-infectious agonising auto immune disorder usually associated with immunological disorders (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) , affects both sexes without any socio-economic variation and poses agonising encumbrance and progressively increasing in present scenario.
Its incidence varies worldwide i.e.-In European country USA has 1-3% of total population, 2-4% western world population and 7.5-8.5 million cases while in India 0.44-2.8% and affect >10 million every year (11) (12) (13) , rate of psoriasis incidence varies according to age, region, and ethinic & combination of environmental and genetic factor. Commonly involved sites are knee, elbow, scalp, tarso, palm, sole of feet but can appear and involve any part of the body and persons with inflammatory bowel disease are more prone Commonly offered therapeutics i.e. -modern molecule, Ayurveda, homeopath or any other, fails to ensure cure of the disease and only assure soothing effect and relieve dermal discomfort with recurrent flare up . (14) (15) (16) Commonly used modern therapeutics areSynthetic retinoids, Immuno suppressor, Recombiant monoclonal antibody, Cholecalciferol orally Topical use-= Allantoin,anthralin and Desonide
AIMS AND OBJECTIVES
Evaluation of immune boosting therapeutics i.e. Self-blood and betamethasone intramuscular to counter the antigen generated in the body and calm the antigen-antibody activity in patients of psoriasis and its sequel psoriatic arthritis
MATERIAL AND METHODS

Material
Patients of psoriasis attending at the OPD of RA. Hospital & Research Centre, Warisaliganj (Nawada) Bihar and Aarogyam Punarjeevan, Ram Bhawan, Ara Garden Road, Jagdeopath, Baily Road Patna 14 with following presentation were selected.
Bleeding on pulling of dry white flake of skin, a confirmatory sign of Psoriasis termed as AUSPETZ sign 17 Common presentation are (18) (19) - Guttate psoriasis: Often starts in childhood or young adulthood, small, red spots, mainly on the torso and limbs. Triggers may be respiratory infections, strep throat, tonsillitis, stress, injury to the skin, and use of anti-malarial and beta-blocker medications.
Inverse psoriasis: bright red, shiny lesions that appear in skin folds, such as the armpits, groin area, and under the breasts 
Methods
Selected patients were interrogated for the history of diseases, drugs taken and their response, examined clinically and investigated for typing the lesion, base line biological status to adjudge the clinical effect or adversity.
Selected patients were classified in to various grade of severity as per clinical presentation (19) (20) Intensity:
Area
The percentage area affected by psoriasis is evaluated in the four regions of the body. In each region, the area is expressed as - 
Calculations for Area
Each of the body area scores is multiplied by the area affected.
 B1 x (0 to 6)= C1
 B2 x (0 to 6)= C2
 B3 x (0 to 6)= C3
 B4 x (0 to 6)= C4
Thus total PASI score = C1 + C2 + C3 + C4.
Other Assessments
The Cardiff Dermatology Life Quality Index is a simple 10-question validated questionnaire to assess the impact of a skin disease on the patient's life. The same team have devised a specific assessment for the quality of life in psoriasis, the Psoriasis Disability Index. Based on these index patients were classified as- In addition this can be categorised as - As per distribution of lesion 164 were having lesion on extremity while 56 were having wide spread lesion and 90 presented with psoriasis sequel. 252 patients were suffering from 5-10 yrs. though 11 cases were suffering since more than 20 yrs.
Table2. Distribution of patients as per distribution of lesion
Table3. Distribution of patients as per duration of illness
Duration of illness (in yrs)
Number of patients Male  Female  Total  <5  15  10  25  5-10  152  100  252  10-15  40  17  57  15-20  50  24  74  >20  07  04  11 Out of all selected cases 50 cases have not taken any treatment while 57 cases have tried all sorts of medication. 
Table4. Distribution of patients as per therapeutic consumed
RESULT
94% patients of psoriasis of varied degree of severity had complete cessation of agonizing presentation in 3 years without any supplementation, drug adversity, therapy withdrawal sequel.
DISCUSSION
Psoriasis, a result of abnormal excessive and rapid growth of epidermis layer of skin and premature maturation of keratinocyte inducing dermal inflammatory cascade involving dendritic cell, macrophages and T cells which move from the dermis to epidermis and secrete inflammatory chemical signals (Cytokine) i.e.-interleukin 36¥, tumour necrosis factor-α, interleukin and interleukin 6 and 22. (21) (22) (23) (24) DNA released from dying cells acts as an inflammatory stimulus and stimulate dendritic cell.
The present study showing complete relief of presentation and non-had any recurrence, relapse or any drug or disease related untoward effects suggest immunological improvement by self-blood due to generation of specific antibody which binds with specific protein and check cell death rate, curb T cell, block Tumour necrosis factor (TNF-α) and stop release of chemical messenger and limit dendrite cell and favours Th2 cells Cytokine secretion pattern over a Th1/Th17cell cytokine profile Dendritic cell bridge the innate immune system and adaptive immune system. (25) (26) (27) (28) (29) (30) (31) (32) Betamethasone calm the antigen and antibody reaction and alleviate the presentation.
